PHARMA EVIDENCE ApS

CVR 34586519 · Private limited company (ApS) · Active · Low risk

PHARMA EVIDENCE ApS is a Private limited company (ApS), founded on , based in Farum. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.4% over the next 12 months, which is 0.3 times the average for Danish companies. 14 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 134k and a net result of DKK 62k. CEO: Tove Holm-Larsen.

Bankruptcy risk for PHARMA EVIDENCE ApS

0.4%
probability of bankruptcy within 12 months
Low risk

0.3 × the average (1.41%) · higher risk than 57% of active Danish companies

Lowest riskHighest risk

Increases the risk

Equity vs. share capital1× · bankruptcy rate 12.9%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×
Employees (latest year)2–5 · bankruptcy rate 10.3%1.2×

Reduces the risk

Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Equity ratio40%–60% · bankruptcy rate 4.6%0.52×
Return on assets15%+ · bankruptcy rate 5.1%0.58×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Loss for the yearNo · bankruptcy rate 5.3%0.60×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
34586519
Status
Active
Company type
Private limited company (ApS)
Founded
(14 years)
Address
Sommervej 9
3520 Farum
Municipality
Furesø
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 80k
Employees
2 (2018)
Auditor
DANSK REVISION ESBJERG GODKENDT REVISIONSAKTIESELSKAB
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 14
Missing annual reportNo
Negative equityNo
Equity ratio47.7%
Current ratio191%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address2
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 64kDKK -173k
Net profitDKK 62kDKK -180k
EquityDKK 134kDKK 72k
Total assetsDKK 282kDKK 212k
CashDKK 1,046–
Short-term debtDKK 148k–
Avg. employees0–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · DANSK REVISION ESBJERG GODKENDT REVISIONSAKTIESELSKAB.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025167
1 Jan 2024 – 31 Dec 2024157
1 Jan 2023 – 31 Dec 2023114
1 Jan 2022 – 31 Dec 202286
1 Jan 2021 – 31 Dec 2021152
1 Jan 2020 – 31 Dec 2020179
1 Jan 2019 – 31 Dec 2019149
1 Jan 2018 – 31 Dec 201884
1 Jan 2017 – 31 Dec 2017115
1 Jan 2016 – 31 Dec 201694
1 Jan 2015 – 31 Dec 2015105
1 Jan 2014 – 31 Dec 2014141
1 Jan 2013 – 31 Dec 2013150
1 Jan 2012 – 31 Dec 2012150

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOTove Holm-LarsenCurrent
Owner (100%)HB World Holding ApSCurrent
Owner (100%)Tove Holm-Larsen
FounderTove Holm-LarsenCurrent

The CEOs' other companies

Tove Holm-Larsen – 3 other companies

Address history (1 moves)

Sommervej 9, 3520 Farum
Sommervej 9, 3520 Farum

Employees per year

Number of employees at PHARMA EVIDENCE ApS per year232012: 220122013: 020132014: 120142015: 320152016: 020162017: 220172018: 22018

Other companies at the same address

Similar companies in Furesø

Questions and answers about PHARMA EVIDENCE ApS

Has PHARMA EVIDENCE ApS gone bankrupt?

No, PHARMA EVIDENCE ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of PHARMA EVIDENCE ApS?

Our model estimates a bankruptcy risk of 0.4% over the next 12 months (low risk), which is 0.3 times the average for Danish companies.

Who is the CEO of PHARMA EVIDENCE ApS?

Tove Holm-Larsen is the CEO of PHARMA EVIDENCE ApS.

Who is the auditor of PHARMA EVIDENCE ApS?

PHARMA EVIDENCE ApS most recently used DANSK REVISION ESBJERG GODKENDT REVISIONSAKTIESELSKAB.

When was PHARMA EVIDENCE ApS founded?

PHARMA EVIDENCE ApS was founded on 29 May 2012.

What is the equity of PHARMA EVIDENCE ApS?

Equity was DKK 134k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.